Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasiliki A Nikolaou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Cosmetic Dermatology|December 16, 2006
Nonablative skin rejuvenationVasiliki A Nikolaou, Alexander J Stratigos, Jeffrey S Dover
The Journal of Investigative Dermatology|January 6, 2012
Melanoma: new insights and new therapiesVasiliki A Nikolaou, Alexander J Stratigos, Keith T Flaherty, et al.
Cancer Causes & Control : CCC|March 1, 2008
Risk associations of melanoma in a Southern European population: results of a case/control studyVasiliki A Nikolaou, Vana Sypsa, Irene Stefanaki, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Cosmetic Dermatology|December 16, 2006
Nonablative skin rejuvenationVasiliki A Nikolaou, Alexander J Stratigos, Jeffrey S Dover
The Journal of Investigative Dermatology|January 6, 2012
Melanoma: new insights and new therapiesVasiliki A Nikolaou, Alexander J Stratigos, Keith T Flaherty, et al.
Cancer Causes & Control : CCC|March 1, 2008
Risk associations of melanoma in a Southern European population: results of a case/control studyVasiliki A Nikolaou, Vana Sypsa, Irene Stefanaki, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 1